The KCa2 Channel Inhibitor AP30663 Selectively Increases Atrial Refractoriness, Converts Vernakalant-Resistant Atrial Fibrillation and Prevents Its Reinduction in Conscious Pigs
Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2020.00159
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 28, 2020
Authors
Publisher
Frontiers Media SA